GlobeNewswire by notified

Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence

Share

Bagsværd, Denmark and Redmond, WA, US,12September 2022 – Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development and data science capabilities.

Through the partnership, Microsoft is providing AI technology, foundational science models and expertise and is working alongside Novo Nordisk’s data scientists and domain experts from early research and development areas to accelerate Novo Nordisk’s R&D.

“We are very excited about this new partnership that allows us to work closely together with key experts from Microsoft as we look to expand our digital science and AI capabilities,” said Lars Fogh Iversen, senior vice president, Digital Science & Innovation at Novo Nordisk. “Together, we are on a path to enable faster and scaled use of AI in drug discovery, ultimately leading to more breakthrough innovations and efficiency gain to better serve the needs of patients.”

“The collaboration with Novo Nordisk is a great opportunity for us to collectively advance the state of the art of AI itself and apply it in a way that amplifies the creativity of human experts,” said Vijay Mital, corporate vice president, AI Architecture & Strategy in Microsoft’s Technology & Research division. “To achieve this ambition, AI needs to learn from every type of information that subject matter experts find valuable and that requires the type of close interaction between multiple disciplines we see in this partnership.”

AI models arising from the collaboration will be applied to a range of use cases of which the first two are in execution.

One use case is focused on automated summarization and analysis of information from sources such as literature, patents, scientific reports and discussion forums in order to gain novel scientific insights.

A second use case aims to develop models that predict a person’s risk of developing atherosclerosis, a cardiovascular disease caused by build-up of fats, cholesterol, and other substances in and on the artery walls. The AI will also be used to identify novel targets and establish biomarkers of the disease.

The companies are taking a platform approach to AI where a set of large models are trained for multiple tasks. This will allow new projects and use cases to be initiated on a continuous basis throughout the multi-year collaboration between the companies.

About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 50,800 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com,Facebook, Twitter, LinkedIn andYouTube.

About Microsoft
Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

Further information

Media:
Ambre Brown Morley+45 3079 9289abmo@novonordisk.com
Natalia Salomao Abrahao (US)  +1 848 304 1027niaa@novonordisk.com
Microsoft Media Relations (WE Communications)+1 425 638 7777rapidresponse@we-worldwide.com
Investors: 
Daniel Muusmann Bohsen +45 3075 2175 dabo@novonordisk.com
David Heiberg Landsted +45 3077 6915 dhel@novonordisk.com
Jacob Martin Wiborg Rode+45 3075 5956jrde@novonordisk.com
Mark Joseph Root (US) +1 848 213 3219 mjhr@novonordisk.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Automox Expands Functionality and Reach with Remote Control and New Global Partnership4.10.2022 15:00:00 CEST | Press release

Product and distribution momentum set to fuel international growth Boulder, Colo, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Automox®, the cloud-native IT operations provider, today announced general availability of its remote control feature, offering global IT teams advanced troubleshooting capabilities from a single cloud-native console. Remote control is a powerful tool for IT teams everywhere. IT administrators often face a mountain of device-related issues daily, ranging from email account errors, password resets, and devices that won’t update, to processes that drain device resources. Without the ability to perform an in-depth investigation directly on the device, providing a fix generally requires significant time from IT teams and multiple tools. With remote control, IT admins can gain immediate access to end-user devices to troubleshoot issues directly. The functionality was developed in-house by Automox’s product team to help IT teams quickly address a wide array of common endpoint i

Huhtamaki launches innovative, recyclable ice cream packaging solution in the US, made with 95% renewable biobased material4.10.2022 15:00:00 CEST | Press release

HUHTAMÄKI OYJ PRESS RELEASE 04.10.2022 AT 16.00 EEST Huhtamaki launchesinnovative, recyclableice cream packaging solution in the US, made with 95% renewable biobased material Paper-based technology allows packaging to enter the North American paper recycling system easily.ConnectedPackaging QR code provides consumers with more information on sustainability. Huhtamaki, a key global provider of sustainable packaging solutions, today launches ICON® packaging, a breakthrough paper technology, initially for use for ice cream containers and lids, which enables recycling in communities with paper product recycling programs across the United States. This is a significant breakthrough in delivering a sustainable solution for consumers which combines Huhtamaki’s proprietary water-based barrier coating with SFI-certified paperboard and results in the entire package being made with 95% renewable biobased material. This enables the ice cream containers and lids to be recycled along with other paper

Tilray Medical Relaunches Cannabis Oral Solution Across Ireland4.10.2022 13:00:00 CEST | Press release

Tilray’s Medical Cannabis Product Now Available and Reimbursed Under Ireland’s Medical Cannabis Access Program LEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that it has successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland under the country’s Medical Cannabis Access Program (MCAP). Tilray’s approved product has also recently received reimbursement approval, which gives patients cost reimbursement and ensures more eligible patients can access quality medical cannabis under Ireland’s MCAP. Denise Faltischek, Tilray Brands’ Chief Strategy Officer and Head of International Business, said, “We are extremely proud to relaunch in Ireland with an expanded footprint. The MCAP reimbursement approval is a tremendous step in providi

Moore Nanotechnology Systems Opens Global Training and Process Development Center in Charlotte, North Carolina4.10.2022 13:00:00 CEST | Press release

SWANZEY, N.H., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Moore Nanotechnology Systems (“Nanotech”), a leading global supplier of ultra-precision machining systems, announces the grand opening of their Global Training and Process Development Center in Charlotte, North Carolina. Mark Boomgarden, President and CEO of Nanotech shared, “Nanotech is very excited to announce the grand opening of our Global Training and Process Development Center in Charlotte, North Carolina. Although the initial focus of this facility is to provide customer-specific training and industry-leading process development, it also provides Nanotech incremental production capacity to meet the demands of a rapidly growing market.” Nanotech purchased and recently completed the upfit of a 50,000 ft2 building located in the Northpark Corporate Park - Charlotte, NC. Nanotech’s core technology and employee base is in Swanzey, New Hampshire, and this foundation is fundamental to the products and services in which they provide. But

FRO - Changes to the Board composition4.10.2022 08:06:57 CEST | Press release

Frontline Ltd. (“Frontline” or “the Company”) announces the appointment of Mr. Marios Demetriades as a Director of the Company. Marios Demetriades is an experienced Financial Services professional with significant experience as a Non-Executive Director in various listed and private companies in the Banking, Infrastructure and Shipping industries. He previously served as the Minister of Transport, Communications and Works for the Republic of Cyprus from 2014 to 2018 and held various positions in the Accounting, Investment and Banking sectors. He is a qualified Chartered Accountant and Chartered Financial Analyst holder and a member of the CFA Institute, the Institute of Chartered Accountants in England and Wales and the Institute of Certified Public Accountants of Cyprus (ICPAC). Mr. Demetriades is a Cypriot citizen and resides in Cyprus. October 4, 2022 The Board of Directors Frontline Ltd. Hamilton, Bermuda Questions should be directed to: Lars H. Barstad, Chief Executive Officer, Fro